All Stories

  1. Impact of hepatitis C virus antibody positivity on mortality and causes of death in people living with HIV in Georgia
  2. Epidemiology of human immunodeficiency virus (HIV) drug resistance in HIV patients with virologic failure of first-line therapy in the country of Georgia
  3. Variation in antiretroviral treatment (ART) coverage and virological suppression among three HIV key populations
  4. The Attitudes, Needs, and Requirements at End of Life in the Republic of Georgia (Comparative Analysis of Groups of Patients With Cancer and Elders)
  5. Uptake of HCV treatment in HIV/HCV coinfected patients across europe in the era of direct-acting antivirals
  6. Persistent disparities in antiretroviral treatment (ART) coverage and virological suppression across Europe, 2004 to 2015
  7. Linkage and retention in HCV care for HIV-infected populations: early data from the DAA era
  8. HIV Care in Central and Eastern Europe:How close are we to the target?
  9. Regression of liver fibrosis over a 24-week period after completing direct-acting antiviral therapy in patients with chronic hepatitis C receiving care within the national hepatitis C elimination program in Georgia
  10. Late presentation of HIV infection in the country of Georgia: 2012-2015
  11. Progress Toward Achieving the UNAIDS 90-90-90 Goals in HIV Care From Diagnosis to Durable Viral Suppression in the Country of Georgia
  12. Cascade of care among HIV patients diagnosed in 2013 in Georgia: Risk factors for late diagnosis and attrition from HIV care
  13. Impact of hepatitis C virus recombinant form RF1_2k/1b on treatment outcomes within the Georgian national hepatitis C elimination program
  14. National Progress Toward Hepatitis C Elimination — Georgia, 2015–2016
  15. Significant Improvements Are Needed in HIV Care Continuum to Meet 90-90-90 Targets in Georgia
  16. Assessment of quality of life in people living with HIV in Georgia
  17. Mismatch between physicians and family members views on communications about patients with chronic incurable diseases receiving care in critical and intensive care settings in Georgia: a quantitative observational survey
  18. The natural history of recent hepatitis C virus infection among blood donors and injection drug users in the country of Georgia
  19. High incidence of the hepatitis C virus recombinant 2k/1b in Georgia: Recommendations for testing and treatment
  20. The cascade of care in the Eastern European country of Georgia
  21. Mortality and Causes of Death Among HIV-Infected Individuals in the Country of Georgia: 1989–2012
  22. Estimating HIV incidence in eastern European country of Georgia: 2010–2012
  23. Evaluation of multiple measures of antiretroviral adherence in the Eastern European country of Georgia
  24. Virologic outcomes of second-line antiretroviral therapy in Eastern European country of Georgia
  25. Poor agreement between interferon-gamma release assays and the tuberculin skin test among HIV-infected individuals in the country of Georgia
  26. IL28B favorable genotype and ultrarapid viral response as the earliest treatment predictors of a sustained viral response in a Georgian cohort infected with the hepatitis C genotype 1
  27. Characterization of HIV‐1 subtypes and drug resistance mutations among individuals infected with HIV in Georgia
  28. Outcomes of Universal Access to Antiretroviral Therapy (ART) in Georgia
  29. Characteristics of HIV-infected women and factors associated with HCV seropositivity in the Republic of Georgia